Law360, New York (March 13, 2009, 12:00 AM EDT) -- A consolidated shareholder derivative lawsuit is being wrapped up as part of a $46.8 billion deal that will see Roche Holding AG acquire the Genentech Inc. stock it doesn't already own for $95 a share, according to an attorney for the plaintiffs.
Stuart Grant, managing director at Grant & Eisenhofer PA, said the settlement would include not only an increased share price, but also protections on the back end for shareholders who chose not to tender.
Court papers describing the deal in detail have not yet...
$46.8B Roche, Genentech Deal Ends Shareholder Suit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
